Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

9.350 -0.260 (-2.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax Inc

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
59 60 Next >
Why Novavax Stock Is Trading Higher Tuesday
Novavax Inc (NASDAQ: NVAX) shares are trading higher Tuesday after the company said its updated COVID-19 vaccine generated neutralizing antibody responses to the 
Via Benzinga
Exposures COVID-19
Why Is Fulcrum Therapeutics (FULC) Stock Up 43% Today?
Fulcrum Therapeutics (FULC) stock is on the rise Tuesday after the FDA removed a clinical hold on its sickle-cell disease candidate. 
Via InvestorPlace
Exposures Product Safety
Novavax (NVAX) Stock Is Getting Ready to Rally Again
Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot. 
Via InvestorPlace
Exposures COVID-19
Why Moderna, BioNTech SE, and Novavax Surged Today
The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign. 
Via The Motley Fool
Exposures COVID-19
Why Is Novavax (NVAX) Stock Up 15% Today?
Investors in Novavax have had a very rough go over the past two years, but NVAX stock is rebounding nicely today. 
Via InvestorPlace
Why Novavax Stock Is Trading Higher Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Monday amid a new COVID wave and rising hospitalizations. 
Via Benzinga
Exposures COVID-19
Is Novavax Stock a Buy Now?
It might be a little too late to invest in this biotech. 
Via The Motley Fool
Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance
The companies are hoping to launch their updated Covid shots in September. 
Via Investor's Business Daily
Exposures COVID-19
Novavax Posted a Profit in Q2. Here's Why It Doesn't Matter
The stock's future remains hazy, at best. 
Via The Motley Fool
3 Biotech Stocks to Sell in August Before They Crash and Burn
These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late. 
Via InvestorPlace
Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Shots
Via Benzinga
Exposures COVID-19
2 Beaten-Down Stocks That Still Aren't Worth Buying
These companies aren't bargains at all. 
Via The Motley Fool
Why Novavax Stock Blasted 8% Higher Today
The continued emergence of a COVID subvariant and a new analyst take juiced investor interest in the company. 
Via The Motley Fool
Exposures COVID-19
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results. 
Via Benzinga
Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 350 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Danger! These 3 Growth Stocks Are a Definite No-Go for Investors.
These three growth stocks may appear to be intriguing speculative bets at current levels, but don't be fooled. 
Via InvestorPlace
3 Healthcare Stocks to Sell in August Before They Crash and Burn
Steer clear of these healthcare stocks, each of which is struggling with significant problems that are impacting their earnings. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
Via Benzinga
Covid Vaccine Maker Novavax Shares Remain Volatile On Surprise Q2 Profit: The Details
Shares of Novavax Inc (NASDAQ: NVAX) after reported Q2 revenue of $424 million, compared to $186 million a year ago, beating the  
Via Benzinga
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
Via Benzinga
Why Are Bank Stocks Down Today?
Bank stocks are falling on Tuesday and investors can look to Moody’s lowering credit ratings as the reason for the decline. 
Via InvestorPlace
Novavax (NVAX) Stock Gets a Boost From Q2 Vaccine Sales
Novavax (NVAX) stock is climbing higher on Tuesday after the vaccine company released earnings results for the second quarter of the year. 
Via InvestorPlace
Small-Cap Slide Ahead? US Stocks Set For Weaker Open On Inflation Anxiety: Analysts Warn 'Mild' Recession Still Likely
The earnings news flow will likely be the driver of the market, given the absence of any market-moving economic data. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.
The company hopes to launch an updated Covid booster shot this fall. But there are several complications. 
Via Investor's Business Daily
Why Novavax Stock Zoomed 13% Higher on Monday
A renewed fight against COVID-19 might be coming. 
Via The Motley Fool
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report. 
Via Benzinga
2 Concerning Numbers Novavax Investors Shouldn't Ignore
Even though the stock has been rallying of late, investors should resist the temptation to get on the bandwagon. 
Via The Motley Fool
Why Novavax Stock Tumbled 28% in the First Half of 2023
It's not quite a one-trick pony, but the bulk of this company's recent revenue has come from a quickly shrinking market. 
Via The Motley Fool
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
59 60 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.